Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) (130, pg 138, 2014)

ROCKET AF Investigators

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)E783-E783
Number of pages1
JournalCirculation
Volume138
Issue number25
DOIs
Publication statusPublished - 18 Dec 2018

Cite this